Hepatitis B virus: from diagnosis to treatment
Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe
liver failure, and death. The infection is most widely transmitted from the infected mother to a …
liver failure, and death. The infection is most widely transmitted from the infected mother to a …
Cardiac troponin biosensor designs: Current developments and remaining challenges
A Campu, I Muresan, AM Craciun, S Cainap… - International Journal of …, 2022 - mdpi.com
Acute myocardial infarction (AMI) is considered as one of the main causes of death,
threating human lives for decades. Currently, its diagnosis relies on electrocardiography …
threating human lives for decades. Currently, its diagnosis relies on electrocardiography …
Viral biomarkers in chronic HBeAg negative HBV infection
E Hadziyannis, A Laras - Genes, 2018 - mdpi.com
Viral biomarkers are important tools for monitoring chronic hepatitis B virus (HBV) hepatitis B
early antigen (HBeAg) negative infection, both in its natural course as well as during and …
early antigen (HBeAg) negative infection, both in its natural course as well as during and …
Hepatitis C virus (HCV) diagnosis via microfluidics
Humans are subjected to various diseases; hence, proper diagnosis helps avoid further
disease consequences. One such severe issue that could cause significant damage to the …
disease consequences. One such severe issue that could cause significant damage to the …
Performance of HCV antigen testing for the diagnosis and monitoring of antiviral treatment: a systematic review and meta‐analysis
GL Flores, JC Mota, LT da Silva Andrade… - BioMed Research …, 2022 - Wiley Online Library
Background and Aims. Active hepatitis C virus (HCV) infection is based on the detection of
HCV RNA that it is effective but presents high cost and the need to hire trained personnel …
HCV RNA that it is effective but presents high cost and the need to hire trained personnel …
Lateral flow assay for hepatitis B detection: a review of current and new assays
From acute to chronic hepatitis, cirrhosis, and hepatocellular cancer, hepatitis B infection
causes a broad spectrum of liver diseases. Molecular and serological tests have been used …
causes a broad spectrum of liver diseases. Molecular and serological tests have been used …
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
Hepatitis B virus (HBV) infections are highly prevalent globally, representing a serious public
health problem. The diverse modes of transmission and the burden of the chronic carrier …
health problem. The diverse modes of transmission and the burden of the chronic carrier …
Hepatitis C viral infection in children: updated review
MA El-Guindi - Pediatric gastroenterology, hepatology & …, 2016 - synapse.koreamed.org
Hepatitis C virus (HCV) infection is a major medical challenge affecting around 200 million
people worldwide. The main site of HCV replication is the hepatocytes of the liver. HCV is a …
people worldwide. The main site of HCV replication is the hepatocytes of the liver. HCV is a …
Nanoparticle-based lateral flow biosensors integrated with loop-mediated isothermal amplification for the rapid and visual diagnosis of hepatitis B virus in clinical …
X Chen, S Wang, Y Tan, J Huang, X Yang… - … in Bioengineering and …, 2021 - frontiersin.org
Hepatitis B virus (HBV) infection remains one of the major public health issues worldwide.
Developing a rapid, sensitive, specific, easy-to-operate, and cost-saving approach for the …
Developing a rapid, sensitive, specific, easy-to-operate, and cost-saving approach for the …
An ultrasensitive electrochemical immunosensor for hepatitis C antibodies based on one-step-eletrosynthetized polypyrrole–graphene nanocomposite
GM Santana, AKS Silva, MV Foguel… - Journal of Materials …, 2022 - Springer
An ultrasensitive label-free electrochemical immunosensor was developed for hepatitis C
antibodies (anti-HCV). Worldwide, it is estimated 71 million people have HCV infection in a …
antibodies (anti-HCV). Worldwide, it is estimated 71 million people have HCV infection in a …